0001053691-17-000001.txt : 20170316 0001053691-17-000001.hdr.sgml : 20170316 20170316162810 ACCESSION NUMBER: 0001053691-17-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170316 DATE AS OF CHANGE: 20170316 EFFECTIVENESS DATE: 20170316 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Diffusion Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001053691 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 300645032 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-282760 FILM NUMBER: 17694915 BUSINESS ADDRESS: STREET 1: 2020 AVON COURT STREET 2: SUITE 4 CITY: CHARLOTTESVILLE STATE: VA ZIP: 22902 BUSINESS PHONE: (434) 220-0718 MAIL ADDRESS: STREET 1: 2020 AVON COURT STREET 2: SUITE 4 CITY: CHARLOTTESVILLE STATE: VA ZIP: 22902 FORMER COMPANY: FORMER CONFORMED NAME: RestorGenex Corp DATE OF NAME CHANGE: 20140307 FORMER COMPANY: FORMER CONFORMED NAME: Stratus Media Group, Inc DATE OF NAME CHANGE: 20080722 FORMER COMPANY: FORMER CONFORMED NAME: FERIS INTERNATIONAL, INC. DATE OF NAME CHANGE: 20080228 D 1 primary_doc.xml X0707 D LIVE 0001053691 Diffusion Pharmaceuticals Inc. 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA VIRGINIA 22902 (434) 220-0718 DELAWARE RestorGenex Corp Stratus Media Group, Inc FERIS INTERNATIONAL, INC. Corporation true David G. Kalergis 2020 Avon Court Suite 4 Charlottesville VA VIRGINIA 22902 Executive Officer Director Mark T. Giles 2020 Avon Court Suite 4 Charlottesville VA VIRGINIA 22902 Director John L. Gainer 2020 Avon Court Suite 4 Charlottesville VA VIRGINIA 22902 Executive Officer Director Isaac Blech 2020 Avon Court Suite 4 Charlottesville VA VIRGINIA 22902 Director Robert W. Adams 2020 Avon Court Suite 4 Charlottesville VA VIRGINIA 22902 Director Alan G. Levin 2020 Avon Court Suite 4 Charlottesville VA VIRGINIA 22902 Director Ben L. Shealy 2020 Avon Court Suite 4 Charlottesville VA VIRGINIA 22902 Executive Officer Thomas S. Byrne 2020 Avon Court Suite 4 Charlottesville VA VIRGINIA 22902 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2017-03-14 false true true true false 0 Maxim Group LLC 120708 None None 405 Lexington Avenue New York NY NEW YORK 10174 All States true 25000000 15830661 9169339 false 145 1498066 true 0 Maxim Group LLC will also receive a 5-year warrant to purchase shares of common stock equal to no more than 10% of the aggregate number of shares of preferred stock sold. Maxim will receive additional commissions on any additional sales in the offering. 0 A portion of the proceeds may be used for general corporate purposes, including to pay salaries of some related persons listed in Item 3. false Diffusion Pharmaceuticals Inc. /s/ David G. Kalergis David G. Kalergis Chairman & CEO 2017-03-16